Athanor Capital, LP Pfizer Inc Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $472,261 - $600,521	-14,110 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $114,331 - $134,137	3,601 Added 34.27%	14,110 $518,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $316,531 - $383,998	10,509 New	10,509 $344,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $616,284 - $880,535	-22,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $750,576 - $851,808	22,800 New	22,800 $893,000

3,258

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.